Position in SIGA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$336,121
-$157,470 QoQ
Shares Held
92,341
+0.1% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 160 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. SIGA ranks #16 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
69,799 | $11,763,923 | |
| 2 | ALKS |
Alkermes plc.
|
170,004 | $8,908,209 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
283,033 | $4,899,301 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,622 | $4,129,828 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
85,564 | $3,510,690 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
74,348 | $3,457,925 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
112,025 | $2,842,074 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
30,741 | $2,544,739 |
All Filings in SIGA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $336,121 | 92,341 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $493,591 | 92,260 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $563,708 | 92,260 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $966,789 | 105,660 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $780,750 | 119,747 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $472,140 | 86,157 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $501,672 | 83,473 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $441,551 | 65,415 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $238,174 | 31,380 | Shares | Sole | 2024-08-12 | |
| 2023-06-30 | $264,958 | 52,467 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $366,487 | 63,737 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $372,062 | 50,552 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $161,853 | 13,977 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $497,739 | 70,203 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $518,218 | 68,912 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $509,570 | 68,954 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $180,575 | 28,754 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $186,712 | 28,725 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $210,175 | 28,910 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,136,861 | 165,482 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,700,691 | 287,765 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $812,901 | 170,063 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||